Active, Not Recruiting
Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers
NCT03598309
- Conditions
- Lung Cancer, Protection Against, Lung Diseases, Lung Neoplasms, +5 more
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States